Global Thebaine
Global Thebaine

Thebaine Comprehensive Study by Type (Food Grade, Pharmaceutical Grade), Application (Oxymorphone, Nalbuphine, Naltrexone, Buprenorphine, Others) Players and Region - Global Market Outlook to 2024

Thebaine Market Segmented into XX Submarkets. | Forecast Years: 2019- 2024  

Nov 2019 Edition 245 Pages 180 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Industry Background:
Thebaine is a natural basic of opium that is chemically similar to both morphine and codeine, but exerts stimulatory rather than depressant effects. Thebaine is an opium poppy abstract used to make OxyContin and a family of equally powerful prescription drugs that have transformed pain management over the last two decades. Tasmania also accounts for a quarter of the world’s codeine and morphine, which are two older painkillers from opium poppies that are still broadly used, mostly outside North America.This growth is primarily driven by Increasing Use in Pharmaceutical Industry Worldwide and Rising Prevalence of Iodine Deficiency.

Globally, a noticeable market trend is evident Growing Awareness among People about the Benefits Related to Thebaine. Major Vendors, such as Mallinckrodt Pharmaceuticals (United Kingdom), Noramco Inc. (United States), Alcaliber (Spain), Tasmanian Alkaloids (Australia), API Labs Inc. (Canada) and Faran Shimi Pharmaceuticals (Iran) etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.

Regulatory Insights:
Thebaine is categorized under the schedule II of Analog Act of U.S. and Controlled Substances Act of international law. It is classified as a Class A drug under the Misuse of Drugs Act 1971 in Great Britain.

Market Drivers
  • Increasing Use in Pharmaceutical Industry Worldwide
  • Rising Prevalence of Iodine Deficiency

Market Trend
  • Growing Awareness among People about the Benefits Related to Thebaine

Restraints
  • Raw Thebaine Can Cause Convulsions When Consumed

Opportunities
Growing Healthcare Infrastructure in Developing Reions
Challenges
Availability of Alternative Products

AdvanceMarketAnalytics follow a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcase the spontaneously changing Vendors landscape impacting the growth of the market. Furthermore, our market researchers extensively analyse the products and services offered by multiple players competing to increase their market share and presence.

Customization of the Report:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase
Report Objectives / Segmentation Covered
By Type
  • Food Grade
  • Pharmaceutical Grade
By Application
  • Oxymorphone
  • Nalbuphine
  • Naltrexone
  • Buprenorphine
  • Others
By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • Spain
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Use in Pharmaceutical Industry Worldwide
      • 3.2.2. Rising Prevalence of Iodine Deficiency
    • 3.3. Market Challenges
      • 3.3.1. Availability of Alternative Products
    • 3.4. Market Trends
      • 3.4.1. Growing Awareness among People about the Benefits Related to Thebaine
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Thebaine, by Type, Application and Region (value and price ) (2013-2018)
    • 5.1. Introduction
    • 5.2. Global Thebaine (Value)
      • 5.2.1. Global Thebaine by: Type (Value)
        • 5.2.1.1. Food Grade
        • 5.2.1.2. Pharmaceutical Grade
      • 5.2.2. Global Thebaine by: Application (Value)
        • 5.2.2.1. Oxymorphone
        • 5.2.2.2. Nalbuphine
        • 5.2.2.3. Naltrexone
        • 5.2.2.4. Buprenorphine
        • 5.2.2.5. Others
      • 5.2.3. Global Thebaine Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. Spain
          • 5.2.3.3.5. United Kingdom
          • 5.2.3.3.6. Netherlands
          • 5.2.3.3.7. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
    • 5.3. Global Thebaine (Price)
      • 5.3.1. Global Thebaine by: Type (Price)
  • 6. Thebaine: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
    • 6.2. Peer Group Analysis (2018)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Mallinckrodt Pharmaceuticals (United Kingdom)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Noramco Inc. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Alcaliber (Spain)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Tasmanian Alkaloids (Australia)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. API Labs Inc. (Canada)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Faran Shimi Pharmaceuticals (Iran)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
  • 7. Global Thebaine Sale, by Type, Application and Region (value and price ) (2019-2024)
    • 7.1. Introduction
    • 7.2. Global Thebaine (Value)
      • 7.2.1. Global Thebaine by: Type (Value)
        • 7.2.1.1. Food Grade
        • 7.2.1.2. Pharmaceutical Grade
      • 7.2.2. Global Thebaine by: Application (Value)
        • 7.2.2.1. Oxymorphone
        • 7.2.2.2. Nalbuphine
        • 7.2.2.3. Naltrexone
        • 7.2.2.4. Buprenorphine
        • 7.2.2.5. Others
      • 7.2.3. Global Thebaine Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. Spain
          • 7.2.3.3.5. United Kingdom
          • 7.2.3.3.6. Netherlands
          • 7.2.3.3.7. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
    • 7.3. Global Thebaine (Price)
      • 7.3.1. Global Thebaine by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Thebaine: by Type(USD Million)
  • Table 2. Thebaine Food Grade , by Region USD Million (2013-2018)
  • Table 3. Thebaine Pharmaceutical Grade , by Region USD Million (2013-2018)
  • Table 4. Thebaine: by Application(USD Million)
  • Table 5. Thebaine Oxymorphone , by Region USD Million (2013-2018)
  • Table 6. Thebaine Nalbuphine , by Region USD Million (2013-2018)
  • Table 7. Thebaine Naltrexone , by Region USD Million (2013-2018)
  • Table 8. Thebaine Buprenorphine , by Region USD Million (2013-2018)
  • Table 9. Thebaine Others , by Region USD Million (2013-2018)
  • Table 10. South America Thebaine, by Country USD Million (2013-2018)
  • Table 11. South America Thebaine, by Type USD Million (2013-2018)
  • Table 12. South America Thebaine, by Application USD Million (2013-2018)
  • Table 13. Brazil Thebaine, by Type USD Million (2013-2018)
  • Table 14. Brazil Thebaine, by Application USD Million (2013-2018)
  • Table 15. Argentina Thebaine, by Type USD Million (2013-2018)
  • Table 16. Argentina Thebaine, by Application USD Million (2013-2018)
  • Table 17. Rest of South America Thebaine, by Type USD Million (2013-2018)
  • Table 18. Rest of South America Thebaine, by Application USD Million (2013-2018)
  • Table 19. Asia Pacific Thebaine, by Country USD Million (2013-2018)
  • Table 20. Asia Pacific Thebaine, by Type USD Million (2013-2018)
  • Table 21. Asia Pacific Thebaine, by Application USD Million (2013-2018)
  • Table 22. China Thebaine, by Type USD Million (2013-2018)
  • Table 23. China Thebaine, by Application USD Million (2013-2018)
  • Table 24. Japan Thebaine, by Type USD Million (2013-2018)
  • Table 25. Japan Thebaine, by Application USD Million (2013-2018)
  • Table 26. India Thebaine, by Type USD Million (2013-2018)
  • Table 27. India Thebaine, by Application USD Million (2013-2018)
  • Table 28. South Korea Thebaine, by Type USD Million (2013-2018)
  • Table 29. South Korea Thebaine, by Application USD Million (2013-2018)
  • Table 30. Taiwan Thebaine, by Type USD Million (2013-2018)
  • Table 31. Taiwan Thebaine, by Application USD Million (2013-2018)
  • Table 32. Australia Thebaine, by Type USD Million (2013-2018)
  • Table 33. Australia Thebaine, by Application USD Million (2013-2018)
  • Table 34. Rest of Asia-Pacific Thebaine, by Type USD Million (2013-2018)
  • Table 35. Rest of Asia-Pacific Thebaine, by Application USD Million (2013-2018)
  • Table 36. Europe Thebaine, by Country USD Million (2013-2018)
  • Table 37. Europe Thebaine, by Type USD Million (2013-2018)
  • Table 38. Europe Thebaine, by Application USD Million (2013-2018)
  • Table 39. Germany Thebaine, by Type USD Million (2013-2018)
  • Table 40. Germany Thebaine, by Application USD Million (2013-2018)
  • Table 41. France Thebaine, by Type USD Million (2013-2018)
  • Table 42. France Thebaine, by Application USD Million (2013-2018)
  • Table 43. Italy Thebaine, by Type USD Million (2013-2018)
  • Table 44. Italy Thebaine, by Application USD Million (2013-2018)
  • Table 45. Spain Thebaine, by Type USD Million (2013-2018)
  • Table 46. Spain Thebaine, by Application USD Million (2013-2018)
  • Table 47. United Kingdom Thebaine, by Type USD Million (2013-2018)
  • Table 48. United Kingdom Thebaine, by Application USD Million (2013-2018)
  • Table 49. Netherlands Thebaine, by Type USD Million (2013-2018)
  • Table 50. Netherlands Thebaine, by Application USD Million (2013-2018)
  • Table 51. Rest of Europe Thebaine, by Type USD Million (2013-2018)
  • Table 52. Rest of Europe Thebaine, by Application USD Million (2013-2018)
  • Table 53. MEA Thebaine, by Country USD Million (2013-2018)
  • Table 54. MEA Thebaine, by Type USD Million (2013-2018)
  • Table 55. MEA Thebaine, by Application USD Million (2013-2018)
  • Table 56. Middle East Thebaine, by Type USD Million (2013-2018)
  • Table 57. Middle East Thebaine, by Application USD Million (2013-2018)
  • Table 58. Africa Thebaine, by Type USD Million (2013-2018)
  • Table 59. Africa Thebaine, by Application USD Million (2013-2018)
  • Table 60. North America Thebaine, by Country USD Million (2013-2018)
  • Table 61. North America Thebaine, by Type USD Million (2013-2018)
  • Table 62. North America Thebaine, by Application USD Million (2013-2018)
  • Table 63. United States Thebaine, by Type USD Million (2013-2018)
  • Table 64. United States Thebaine, by Application USD Million (2013-2018)
  • Table 65. Canada Thebaine, by Type USD Million (2013-2018)
  • Table 66. Canada Thebaine, by Application USD Million (2013-2018)
  • Table 67. Mexico Thebaine, by Type USD Million (2013-2018)
  • Table 68. Mexico Thebaine, by Application USD Million (2013-2018)
  • Table 69. Thebaine: by Type(USD/Units)
  • Table 70. Company Basic Information, Sales Area and Its Competitors
  • Table 71. Company Basic Information, Sales Area and Its Competitors
  • Table 72. Company Basic Information, Sales Area and Its Competitors
  • Table 73. Company Basic Information, Sales Area and Its Competitors
  • Table 74. Company Basic Information, Sales Area and Its Competitors
  • Table 75. Company Basic Information, Sales Area and Its Competitors
  • Table 76. Thebaine: by Type(USD Million)
  • Table 77. Thebaine Food Grade , by Region USD Million (2019-2024)
  • Table 78. Thebaine Pharmaceutical Grade , by Region USD Million (2019-2024)
  • Table 79. Thebaine: by Application(USD Million)
  • Table 80. Thebaine Oxymorphone , by Region USD Million (2019-2024)
  • Table 81. Thebaine Nalbuphine , by Region USD Million (2019-2024)
  • Table 82. Thebaine Naltrexone , by Region USD Million (2019-2024)
  • Table 83. Thebaine Buprenorphine , by Region USD Million (2019-2024)
  • Table 84. Thebaine Others , by Region USD Million (2019-2024)
  • Table 85. South America Thebaine, by Country USD Million (2019-2024)
  • Table 86. South America Thebaine, by Type USD Million (2019-2024)
  • Table 87. South America Thebaine, by Application USD Million (2019-2024)
  • Table 88. Brazil Thebaine, by Type USD Million (2019-2024)
  • Table 89. Brazil Thebaine, by Application USD Million (2019-2024)
  • Table 90. Argentina Thebaine, by Type USD Million (2019-2024)
  • Table 91. Argentina Thebaine, by Application USD Million (2019-2024)
  • Table 92. Rest of South America Thebaine, by Type USD Million (2019-2024)
  • Table 93. Rest of South America Thebaine, by Application USD Million (2019-2024)
  • Table 94. Asia Pacific Thebaine, by Country USD Million (2019-2024)
  • Table 95. Asia Pacific Thebaine, by Type USD Million (2019-2024)
  • Table 96. Asia Pacific Thebaine, by Application USD Million (2019-2024)
  • Table 97. China Thebaine, by Type USD Million (2019-2024)
  • Table 98. China Thebaine, by Application USD Million (2019-2024)
  • Table 99. Japan Thebaine, by Type USD Million (2019-2024)
  • Table 100. Japan Thebaine, by Application USD Million (2019-2024)
  • Table 101. India Thebaine, by Type USD Million (2019-2024)
  • Table 102. India Thebaine, by Application USD Million (2019-2024)
  • Table 103. South Korea Thebaine, by Type USD Million (2019-2024)
  • Table 104. South Korea Thebaine, by Application USD Million (2019-2024)
  • Table 105. Taiwan Thebaine, by Type USD Million (2019-2024)
  • Table 106. Taiwan Thebaine, by Application USD Million (2019-2024)
  • Table 107. Australia Thebaine, by Type USD Million (2019-2024)
  • Table 108. Australia Thebaine, by Application USD Million (2019-2024)
  • Table 109. Rest of Asia-Pacific Thebaine, by Type USD Million (2019-2024)
  • Table 110. Rest of Asia-Pacific Thebaine, by Application USD Million (2019-2024)
  • Table 111. Europe Thebaine, by Country USD Million (2019-2024)
  • Table 112. Europe Thebaine, by Type USD Million (2019-2024)
  • Table 113. Europe Thebaine, by Application USD Million (2019-2024)
  • Table 114. Germany Thebaine, by Type USD Million (2019-2024)
  • Table 115. Germany Thebaine, by Application USD Million (2019-2024)
  • Table 116. France Thebaine, by Type USD Million (2019-2024)
  • Table 117. France Thebaine, by Application USD Million (2019-2024)
  • Table 118. Italy Thebaine, by Type USD Million (2019-2024)
  • Table 119. Italy Thebaine, by Application USD Million (2019-2024)
  • Table 120. Spain Thebaine, by Type USD Million (2019-2024)
  • Table 121. Spain Thebaine, by Application USD Million (2019-2024)
  • Table 122. United Kingdom Thebaine, by Type USD Million (2019-2024)
  • Table 123. United Kingdom Thebaine, by Application USD Million (2019-2024)
  • Table 124. Netherlands Thebaine, by Type USD Million (2019-2024)
  • Table 125. Netherlands Thebaine, by Application USD Million (2019-2024)
  • Table 126. Rest of Europe Thebaine, by Type USD Million (2019-2024)
  • Table 127. Rest of Europe Thebaine, by Application USD Million (2019-2024)
  • Table 128. MEA Thebaine, by Country USD Million (2019-2024)
  • Table 129. MEA Thebaine, by Type USD Million (2019-2024)
  • Table 130. MEA Thebaine, by Application USD Million (2019-2024)
  • Table 131. Middle East Thebaine, by Type USD Million (2019-2024)
  • Table 132. Middle East Thebaine, by Application USD Million (2019-2024)
  • Table 133. Africa Thebaine, by Type USD Million (2019-2024)
  • Table 134. Africa Thebaine, by Application USD Million (2019-2024)
  • Table 135. North America Thebaine, by Country USD Million (2019-2024)
  • Table 136. North America Thebaine, by Type USD Million (2019-2024)
  • Table 137. North America Thebaine, by Application USD Million (2019-2024)
  • Table 138. United States Thebaine, by Type USD Million (2019-2024)
  • Table 139. United States Thebaine, by Application USD Million (2019-2024)
  • Table 140. Canada Thebaine, by Type USD Million (2019-2024)
  • Table 141. Canada Thebaine, by Application USD Million (2019-2024)
  • Table 142. Mexico Thebaine, by Type USD Million (2019-2024)
  • Table 143. Mexico Thebaine, by Application USD Million (2019-2024)
  • Table 144. Thebaine: by Type(USD/Units)
  • Table 145. Research Programs/Design for This Report
  • Table 146. Key Data Information from Secondary Sources
  • Table 147. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Thebaine: by Type USD Million (2013-2018)
  • Figure 5. Global Thebaine: by Application USD Million (2013-2018)
  • Figure 6. South America Thebaine Share (%), by Country
  • Figure 7. Asia Pacific Thebaine Share (%), by Country
  • Figure 8. Europe Thebaine Share (%), by Country
  • Figure 9. MEA Thebaine Share (%), by Country
  • Figure 10. North America Thebaine Share (%), by Country
  • Figure 11. Global Thebaine: by Type USD/Units (2013-2018)
  • Figure 12. Global Thebaine share by Players 2018 (%)
  • Figure 13. Global Thebaine share by Players (Top 3) 2018(%)
  • Figure 14. BCG Matrix for key Companies
  • Figure 15. Mallinckrodt Pharmaceuticals (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 16. Mallinckrodt Pharmaceuticals (United Kingdom) Revenue: by Geography 2018
  • Figure 17. Noramco Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 18. Noramco Inc. (United States) Revenue: by Geography 2018
  • Figure 19. Alcaliber (Spain) Revenue, Net Income and Gross profit
  • Figure 20. Alcaliber (Spain) Revenue: by Geography 2018
  • Figure 21. Tasmanian Alkaloids (Australia) Revenue, Net Income and Gross profit
  • Figure 22. Tasmanian Alkaloids (Australia) Revenue: by Geography 2018
  • Figure 23. API Labs Inc. (Canada) Revenue, Net Income and Gross profit
  • Figure 24. API Labs Inc. (Canada) Revenue: by Geography 2018
  • Figure 25. Faran Shimi Pharmaceuticals (Iran) Revenue, Net Income and Gross profit
  • Figure 26. Faran Shimi Pharmaceuticals (Iran) Revenue: by Geography 2018
  • Figure 27. Global Thebaine: by Type USD Million (2019-2024)
  • Figure 28. Global Thebaine: by Application USD Million (2019-2024)
  • Figure 29. South America Thebaine Share (%), by Country
  • Figure 30. Asia Pacific Thebaine Share (%), by Country
  • Figure 31. Europe Thebaine Share (%), by Country
  • Figure 32. MEA Thebaine Share (%), by Country
  • Figure 33. North America Thebaine Share (%), by Country
  • Figure 34. Global Thebaine: by Type USD/Units (2019-2024)
Some of the key companies/manufacturers profiled in the report
  • Mallinckrodt Pharmaceuticals (United Kingdom)
  • Noramco Inc. (United States)
  • Alcaliber (Spain)
  • Tasmanian Alkaloids (Australia)
  • API Labs Inc. (Canada)
  • Faran Shimi Pharmaceuticals (Iran)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation